clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT00489151 |
P4135 | maximum age | 70 | |
P1050 | medical condition | hepatitis B | Q6853 |
P2899 | minimum age | 18 | |
P1132 | number of participants | 70 | |
P4844 | research intervention | adefovir | Q353551 |
lamivudine | Q422631 | ||
adefovir dipivoxil | Q28851735 | ||
P6153 | research site | Queen Mary Hospital, Hong Kong | Q7270465 |
P580 | start time | 2005-06-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy |
Search more.